Nash Kevin C's Form 4 filing
Gentex Corp (GNTX) · filed Feb 19, 2026
- Accession no.
- 0001577359-26-000001
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $296.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nash Kevin CCIK 0001577359 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | AGrant or awardAcquired | +38,181 | $0.00 | $0 | 92,485 | Direct | |
| Feb 17, 2026 | Common Stock | FTax withholdingDisposed | −16,864 | $24.89 | −$419,744.96 | 75,621 | Direct | |
| Feb 17, 2026 | Common Stock | FTax withholdingDisposed | −4,306 | $24.89 | −$107,176.34 | 71,315 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −6,317 | $24.98 | −$157,798.66 | 64,998 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −5,568 | $24.98 | −$139,088.64 | 59,430 | Direct | |
| Feb 19, 2026 | Common Stock | AGrant or awardAcquired | +13,880 | $0.00 | $0 | 73,310 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.